Fissures

    La Roche-Posay
  • May 2022
  • 15min

Therapeutic classes inducing this adverse event
EGFR inhibitor, BRAF inhibitor, MEK inhibitor

Fissures
Linear ulceration
Linear ulceration

SIMPLIFIED GRADING

Painless


References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

SIMPLIFIED GRADING

Moderate pain (VAS < 6) or limiting instrumental ADL


References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

SIMPLIFIED GRADING

Severe pain (VAS ≥ 6) OR Limiting self care ADL


References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

Browse for more adverse events